Nu Skin Enterprises 2025 Q1 Earnings Record Net Income Surges Over 20,000%

Nu Skin Enterprises(NUS) reported its fiscal 2025 Q1 earnings on May 08th, 2025. The company exceeded expectations with a remarkable turnaround in profitability, achieving an EPS of $2.16. This represents a significant positive change from a loss of $0.01 per share in the prior year. The company's guidance for Q2 2025 was in line with expectations, projecting revenue between $355 million and $390 million and an EPS of $0.20 to $0.30. For the full year 2025, Nu Skin anticipates revenue of $1.48 billion to $1.62 billion and an EPS between $2.80 to $3.20, reflecting stability despite ongoing macroeconomic uncertainties.

Revenue
Nu Skin Enterprises reported a total revenue of $364.49 million in 2025 Q1, marking a 12.7% decrease from the previous year's $417.31 million. The company faced challenges including a 3.0% negative impact from foreign exchange rates, equating to a $12.3 million reduction in revenue.

Earnings/Net Income
Nu Skin Enterprises achieved a remarkable turnaround in profitability with net income of $107.52 million in 2025 Q1, reversing from a net loss of $533,000 in 2024 Q1. The company set a new record high for fiscal Q1 net income, the highest in over 20 years. The EPS of $2.16 is considered strong given the previous year's loss.

Price Action
The stock price of Nu Skin Enterprises climbed 6.02% during the latest trading day, remained unchanged during the most recent full trading week, and decreased by 0.96% month-to-date.

Post-Earnings Price Action Review
The strategy of buying Nu Skin Enterprises shares after a revenue increase and holding for 30 days resulted in significant losses over the past five years. Despite the recent positive earnings report, the company's share price declined by 34% over the five years, with an annualized return of -6.8%. This indicates that the strategy failed to generate profit, and the holding period of 30 days did not improve outcomes. The decline in share price can be attributed to the company's financial performance, evidenced by a 49.9% decline in earnings per share (EPS) over the past five years. Additionally, market sentiment towards the company remained negative, as reflected by a significant drop in share price, which fell by 51.8% over the past year. Investors following this approach would have incurred substantial losses.

CEO Commentary
Ryan Napierski, President and CEO of Nu Skin Enterprises, expressed satisfaction with achieving revenue at the high end of the guidance range and exceeding adjusted earnings forecasts. He highlighted growth in Latin America and the Rhyz manufacturing segment while noting ongoing consumer caution in premium beauty due to inflation and tariffs globally. Napierski emphasized the focus on product launches, particularly the upcoming Prysm iO intelligent wellness device, which aims to enhance customer satisfaction and loyalty. He also pointed out the strategic groundwork for expansion into India, set for a market pre-opening in Q4 2025, underlining a commitment to improving margins across the board.

Guidance
For Q2 2025, Nu Skin Enterprises projects revenue between $355 million and $390 million, with an expected EPS of $0.20 to $0.30. For the full year 2025, the company anticipates revenue of $1.48 billion to $1.62 billion and an EPS between $2.80 and $3.20. This guidance reflects a foreign currency impact of approximately 3% and maintains the adjusted annual outlook despite ongoing macroeconomic uncertainties.

Additional News
Nu Skin Enterprises announced its board of directors has declared a quarterly cash dividend of $0.06 per share, to be paid on June 11, 2025, to shareholders of record on May 30, 2025. Additionally, the company completed a strategic transaction involving the sale of its Mavely affiliate marketing technology platform for approximately $250 million, which includes cash and a minority equity stake. This transaction is part of Nu Skin's efforts to enhance shareholder value and streamline operations. Furthermore, Nu Skin announced a share repurchase program, authorizing $157.4 million for buybacks to further strengthen shareholder returns.